Orito E, Ichida T, Sakugawa H, Sata M, Horiike N, Hino K, Okita K, Okanoue T, Iino S, Tanaka E, Suzuki K, Watanabe H, Hige S, Mizokami M
Second Department of Medicine, Nagoya City University Medical School, Nagoya, Japan.
Hepatology. 2001 Sep;34(3):590-4. doi: 10.1053/jhep.2001.27221.
The geographic distribution of hepatitis B virus (HBV) genotypes in Japan and its clinical relevance are poorly understood. We studied 731 Japanese patients with chronic HBV infection. HBV genotype was determined by the restriction fragment length polymorphism (RFLP) method after polymerase chain reaction (PCR). Of the 720 patients with positive PCR, 12 (1.7%) were HBV genotype A, 88 (12.2%) were genotype B, 610 (84.7%) were genotype C, 3 (0.4%) were genotype D, and 7 (1.0%) were of mixed genotype. Over 94% of patients on the Japanese mainland had genotype C, while 60% of the patients on Okinawa, the most southern islands, and 22.9% in the Tohoku area, the northern part of the mainland, harbored genotype B. Compared with genotype C patients, genotype B patients were older (53.6 to 42.2 years; P <.01), had a lower rate of positive hepatitis B e antigen (HBeAg) (18.4% to 50.6%; P <.01), and a lower level of serum HBV DNA (5.02 to 5.87 log genome equivalents (LGE)/mL; P <.01). The mean age of the genotype B patients with hepatocellular carcinoma was 70.1 +/- 9.2 years, compared with 55.2 +/- 9.7 of genotype C patients (P <.01). These results indicate that genotypes C and B are predominant in Japan, and there are significant differences in geographic distribution and clinical characteristics among the patients with the different genotypes.
日本乙型肝炎病毒(HBV)基因型的地理分布及其临床相关性尚不清楚。我们研究了731例日本慢性HBV感染患者。聚合酶链反应(PCR)后,采用限制性片段长度多态性(RFLP)方法确定HBV基因型。在720例PCR阳性患者中,12例(1.7%)为HBV A基因型,88例(12.2%)为B基因型,610例(84.7%)为C基因型,3例(0.4%)为D基因型,7例(1.0%)为混合基因型。日本本土超过94%的患者为C基因型,而最南部岛屿冲绳县60%的患者以及本土北部东北地区22.9%的患者为B基因型。与C基因型患者相比,B基因型患者年龄更大(53.6岁对42.2岁;P<.01),乙肝e抗原(HBeAg)阳性率更低(18.4%对50.6%;P<.01),血清HBV DNA水平更低(5.02对5.87 log基因组当量(LGE)/mL;P<.01)。肝细胞癌B基因型患者的平均年龄为70.1±9.2岁,而C基因型患者为55.2±9.7岁(P<.01)。这些结果表明,C和B基因型在日本占主导地位,不同基因型患者在地理分布和临床特征上存在显著差异。